Senior insider sale
Chief Medical Officer at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$796.6K
30K shares
What this filing means
WELGUS HOWARD G. plans to sell 30K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $796.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001628280-26-013371
Officer· Chief Medical Officer
Since Jan 2020
30K
Shares to sell
$796.6K
Approx. market value
10K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock option exercise
Cash
6/4/2018
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/4/2018 | Stock option exercise Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10K
Market value
$250.5K
2/2/2026
—Completed
Units to sell
10K
Market value
$289.6K
1/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$256.5K
3/2/2026
Total
Units
30K
Value
$796.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/2/2026 | 10K | $250.5K | — | Completed |
1/2/2026 | 10K | $289.6K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 10K | $256.5K | NASDAQ | Planned |
| Total | 30K | $796.6K | ||